Updated March 5 at 5:45pm
Biotechnology
43 results total, viewing 11 - 20
Amgen Inc., the world’s largest biotechnology company by revenue, disappointed analysts with lower-than-expected sales of its top drug as executives assured investors the drop was seasonal and they were on target to meet their 2014 projections. more
Big Brothers Big Sisters of the Ocean State recently received a $30,000 Amgen Foundation Grant to develop and implement a Science, Technology, Engineering and Mathematics curriculum into the mentoring agency’s site-based programming. more
The co-founder and president of MedMates, Rhode Island’s first health care technology network group, and co-founder and director of an emerging health-tech company, Aspiera Medical, talks about starting a company in Rhode Island and what he expects MedMates to look like down the road. more
U.S. stocks fluctuated as investors weighed better-than-estimated bank earnings against Federal Reserve concerns about valuations for some social-media and biotech companies. more
Medical robotics company Medrobotics Corp. announced the appointment on March 17 of Russell M. Singleton as the company’s senior vice president of research and development. more
The second annual SkillsUSA Rhode Island student bioscience competition on March 8 drew 36 students from Coventry High School, Warwick Veterans Memorial High School, Davies Career and Technical High School, and the Woonsocket Career and Technical Center. more
Nabsys Inc. has begun a search for CEO candidates with experience in life sciences commercialization, as the company moves closer to bringing its high-speed DNA sequencing technology to market, current CEO Dr. Barrett Bready told Providence Business News. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »